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Objective: To assess trends of stroke hospitalization rates, inpatient mortality, and health care resource
use in young (aged 44 years), midlife (aged 45-64 years), and older (aged 65 years) adults.
Patients and Methods: We studied the National Inpatient Sample database (January 1, 2002 to December
31, 2017) to analyze stroke-related hospitalizations. We identified data using the International Classification
of Diseases, Ninth/Tenth Revision codes.
Results: Of 11,381,390 strokes, 79% (n¼9,009,007) were ischemic and 21% (n¼2,372,383) were
hemorrhagic. Chronic diseases were more frequent in older adults; smoking, alcoholism, and migraine
were more prevalent in midlife adults; and coagulopathy and intravenous drug abuse were more common
in young patients with stroke. The hospitalization rates of stroke per 10,000 increased overall (31.6 to
33.3) in young and midlife adults while decreasing in older adults. Although mortality decreased overall
and in all age groups, the decline was slower in young and midlife adults than older adults. The mean
length of stay significantly decreased in midlife and older adults and increased in young adults. The
inflation-adjusted mean cost of stay increased consistently, with an average annual growth rate of 2.44% in
young, 1.72% in midlife, and 1.45% in older adults owing to the higher use of health care resources. These
trends were consistent in both ischemic and hemorrhagic stroke.
Conclusion: Stroke-related hospitalization and health care expenditure are increasing in the United States,
particularly among young and midlife adults. A higher cost of stay counterbalances the benefits of
reducing stroke and mortality in older patients.
ª 2021 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
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the end of this article.T he epidemiologic profile of stroke hasevolved over the years in the UnitedStates. Stroke remained the fifth major
cause of death in the country, accounting for
more than 140,000 deaths each year.1,2 Stroke
imparts a significant economic burden on the
health system and costs around $34 billion
per annum in the United States.3 The National
Health and Aging Trends Study reported that
care costs for elderly stroke survivors are
approximately $40 billion per year.4 Over
the years, advances in stroke care throughMayo Clin Proc Inn Qual Out n April 2021;5(2):431-441 n https://d
www.mcpiqojournal.org n ª 2021 Mayo Foundation for Medical Ed
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-structured quality enhancement programs
have resulted in an overall decline in stroke.5
However, stroke-related morbidity and mor-
tality vary across different age groups.1,5
The relative decline in stroke-related mor-
tality among older adults (aged 65 years)
was found to be almost twice the rate of
decline in midlife (45-64 years) adults be-
tween 1999 and 2003.1,5 The Atherosclerosis
Risk in Communities Study cohort demon-
strated an approximately 50% decline in
incident stroke among older patients butoi.org/10.1016/j.mayocpiqo.2021.01.015
ucation and Research. Published by Elsevier Inc. This is an open access article under
nc-nd/4.0/).
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432stable stroke rates in younger adults. However,
stroke-related mortality rates were reduced in
the latter between 1987 and 2011.6 In
contrast, another National Inpatient Sample
(NIS) report from 1995 to 2012 illustrated a
significant increase in stroke hospitalization
rates in young adults aged 18 to 54 years.5
In the backdrop of fluctuating patterns,
assessing the most recent stroke-stratified
trends by age groups becomes relevant to pub-
lic health interventions to prevent the onset of
stroke and subsequent treatment strategies.
Moreover, there is a paucity of data on the
economic burden of stroke across different
age categories. To address these evidence
gaps, we analyzed data from the largest US
administrative claimsebased database and
examined characteristics and trends in the
prevalence, mortality, health care resource
use, and stroke expenditure across different
age groups in the country.
PATIENTS AND METHODS
Setting
The NIS database is part of the Healthcare
Cost and Utilization Project (HCUP) data-
bases,7 sponsored by the Agency for Health-
care Research and Quality. The NIS is the
largest publicly available all-payer administra-
tive claimsebased database of hospital inpa-
tient stays, which contains the clinical and
resource use information abstracted from dis-
charges from 47 US states covering greater
than 97% of the US population. The annual
sample encompasses approximately 8 million
discharges, representing 20% of US inpatient
hospitalizations across different geographic
regions and hospital types. This study was
exempt from institutional review board
approval given the NIS database's deidentified
nature and public availability.
Study Design
We conducted a longitudinal observational
analysis using data from January 1, 2002, to
December 31, 2017, to identify stroke-related
hospitalizations in adults (aged 18 years) as
captured in NIS. We identified stroke-related
hospitalizations using the International Classifi-
cation of Diseases, Ninth Revision, Clinical Modifi-
cation (ICD-9-CM) and ICD, Tenth Revision,
Clinical Modification (ICD-10-CM) codes,Mayo Clin Proc Inn Qual Out n April 2021respectively. Supplemental Table 1 (available
online at https://mcpiqojournal.org) reports a
complete list of diagnosis codes).
Exposures
The exposure of interest for the present
analysis was age, and this was modeled in 3
groups as young (aged 44 years), midlife
(aged 45-64 years), and older (aged 65
years) adults.8-12
Outcomes
Several relevant features were described
among patients with stroke, including demo-
graphic characteristics, frequency of stroke
subtypes (ischemic and hemorrhagic), comor-
bid conditions (based on 29 Elixhauser
comorbid conditions using ICD-9-CM and
ICD-10-CM codes),13 insurance/payer, house-
hold income, and discharge disposition. We
classified discharge disposition as: (1) home
(routine or with home health), (2) short-term
care facility (short-term rehabilitation or inpa-
tient rehabilitation), (3) long-term care facility
(skilled nursing and intermediate-care facility),
and (4) against medical advice. We then
computed trends in stroke hospitalization
rates, inpatient mortality, mean length of stay
(LOS), and adjusted mean cost of care.
Statistical Analyses
The national estimates of the entire US hospi-
talized population were calculated using the
Agency for Healthcare Research and Quality
sampling and weighting method. Before
2012, the Nationwide Inpatient Sample (NIS)
contains discharge data from a national sample
of community hospitals.14 In 2012, the
Nationwide Inpatient Sample was renamed
the National Inpatient Sample to reflect the
sampling methodology change. The National
Inpatient Sample uses a redesigned sampling
method for a more accurate representation of
national discharge data. The revised database
contains a sample of discharge records from
all hospitals participating in HCUP (compared
with the previous NIS that contained all
discharge records from a sample of hospitals).
The new NIS contains data for more than 7
million hospital stays each year that can be
weighted to make national estimates. To
account for this methodology change, HCUP
came up with new weights that would allow;5(2):431-441 n https://doi.org/10.1016/j.mayocpiqo.2021.01.015
www.mcpiqojournal.org




Stroke (N¼11,381,390), no. (%) 648,853 (5.7) 3,148,862 (27.7) 7,583,675 (66.6)
Stroke subtypes, no. (%)
Hemorrhagic stroke 232,685 (35.9) 746,297 (23.7) 1,393,401 (18.4)
Ischemic stroke 416,168 (64.1) 2,402,565 (76.3) 6,190,274 (81.6)
Demographic characteristics
Age (y), median (interquartile range) 38 (32-42) 57 (52-61) 79 (72-85)
Female sex, no. (%) 316,349 (48.8) 1,356,485 (43.1) 4,239,664 (55.9)
Race, no. (%)
White 280,513 (51.0) 1,577,611 (58.4) 4,878,285 (75.6)
Black 144,786 (26.3) 663,286 (24.6) 767,825 (11.9)
Hispanic 79,451 (14.4) 272,158 (10.1) 434,061 (6.7)
Others 45,428 (8.3) 188,528 (7.0) 372,510 (5.8)
Comorbid conditions, no. (%)
Hypertension 285,357 (45.0) 2,230,605 (72.5) 5,664,427 (76.5)
Diabetes mellitus 106,987 (16.9) 1,085,248 (35.2) 2,299,152 (31.1)
Smoking 157,436 (24.3) 819,978 (26.0) 528,627 (7.0)
Alcoholism 45,622 (7.2) 271,611 (8.8) 169,193 (2.3)
Heart failure 50,616 (7.8) 376,819 (12.0) 1,493,850 (19.7)
Migraine 17,503 (2.7) 91,937 (2.9) 130,712 (1.7)
Previous stroke 51,859 (8.0) 423,873 (13.5) 1,184,302 (15.6)
Cancer 27,427 (4.2) 164,192 (5.2) 428,556 (5.7)
Metastatic cancer 12,581 (1.9) 105,533 (3.4) 198,774 (2.6)
Coronary artery disease 27,928 (4.3) 526,981 (16.7) 2,075,762 (27.4)
Chronic lung disease 50,629 (8.0) 437,259 (14.2) 1,232,923 (16.7)
Vascular disease 37,981 (6.0) 220,963 (7.2) 684,907 (9.3)
Anemia 78,493 (12.4) 350,164 (11.4) 1,040,623 (14.1)
Coagulopathy 45,757 (7.2) 179,989 (5.9) 360,478 (4.9)
Atrial fibrillation/flutter 18,713 (2.9) 273,159 (8.7) 2,233,581 (29.5)
Liver cirrhosis 7,977 (1.2) 56,646 (1.8) 46,239 (0.6)
Long-term dialysis/end-stage renal disease 17,503 (2.7) 91,937 (2.9) 130,712 (1.7)
Intravenous drug use 54,148 (8.3) 136,123 (4.3) 2,3587 (0.3)
Insurance/payer, no. (%)
Medicare 61,152 (9.5) 616,972 (19.6) 6,736,387 (88.9)
Medicaid 176,252 (27.2) 594,758 (18.9) 118,907 (1.6)
Private insurance 279,426 (43.2) 1,401,584 (44.6) 580,990 (7.7)
Self-pay 92039 (14.2) 347932 (11.1) 50123 (0.7)
No charge/others 37950 (5.9) 179329 (5.7) 88485 (1.2)
Household income, no. (%)
0-25th percentile 202,581 (32.1) 1,013,034 (33.0) 1,956,900 (26.3)
26th-50th percentile 162,419 (25.7) 792,401 (25.8) 1,935,811 (26.0)
51st-75th percentile 144,440 (22.9) 690,366 (22.5) 1,809,418 (24.3)
76th-100th percentile 122,630 (19.4) 571,451 (18.6) 1,734,281 (23.3)
aFor all comparisons, statistical significance was P<.001.
STROKE IN THE UNITED STATESfor trend analysis if applied to years before
2012. These weights were calculated in the
same way as the weights for the redesigned
2012 NIS. Therefore, the weights “trendwt”Mayo Clin Proc Inn Qual Out n April 2021;5(2):431-441 n https://d
www.mcpiqojournal.orgreplaces standard discharge weights in years
before 2012, whereas standard discharge
weights are used after 2012. Further details
on weights performed in the analysis areoi.org/10.1016/j.mayocpiqo.2021.01.015 433
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434available at https://www.hcup-us.ahrq.gov/db/
nation/nis/trendwghts.jsp.
We defined cost of care as estimated total
expense in US dollars incurred because of hos-
pital services provided (eg, wages, supplies, and
utility costs). The NIS database provides the es-
timates of hospital charges; the bill charged by a
hospital for admission. To further calculate the
actual cost, HCUP provides Cost-to-Charge Ra-
tio files to estimate the cost of resource use for
inpatient hospitals. For the cost, HCUP com-
piles the information from the hospital account-
ing reports collected by the Centers for
Medicare & Medicaid Services. Because Cost-
to-Charge Ratio is a ratio between hospital
charges and actual cost, the estimate can be
multiplied with each hospital charge to obtain
the cost of care per patient per hospital stay.
We adjusted the cost of the stay for inflation
with comparison to December 2017 (https://
data.bls.gov/cgi-bin/cpicalc.pl).13
We estimated the annual stroke-related
hospitalization rates per 10,000 US adults
(Supplemental Table 2, available online at
https://mcpiqojournal.org). We calculated the
weighted average of the annual percent change
(AAPC) with 95% CIs in stroke rates and the
absolute number and proportion of mortality
for the entire study period using the Joinpoint
Regression Program, version 4.7.0.0. The soft-
ware takes trend data (eg, absolute counts,
rates, or proportion) and fits the simplest join-
point model that the data allow. The user sup-
plies the minimum and maximum number of
joinpoints. The program starts with the mini-
mum number of joinpoints (eg, 0 joinpoints,
which is a straight line) and tests whether
more joinpoints are statistically significant
and must be added to the model (up to that
maximum number). This enables the user to
test that an apparent change in trend is statis-
tically significant. The tests of significance use
a Monte Carlo permutation method. The
models may incorporate estimated variation
for each point (eg, when the responses are
age-adjusted rates) or use a Poisson model of
variation. The models may also be linear on
the log of the response (eg, for calculating
annual percentage rate change).15
Categorical variables were presented as
number and percentage, and continuous vari-
ables were reported as mean  SD or median
and interquartile range. Categorical variablesMayo Clin Proc Inn Qual Out n April 2021were compared across age strata (young,
midlife, and older) using Pearson c2 test and
Fisher exact test, and continuous variables
were compared using Kruskal-Wallis testing.
Temporal trends in continuous variables
were examined graphically and with linear
regression. We performed subgroup analyses
for ischemic and hemorrhagic stroke
(Supplemental Tables 3-8, available online at
https://mcpiqojournal.org). We performed
prespecified analyses to determine the compo-
nents of cost of care (Supplemental Table 9,
available online at https://mcpiqojournal.org).
We set statistical significance (2 sided) at
.05. Analyses were performed using Statistical




Between 2002 and 2017, a total of 11,381,390
weighted cases of stroke were identified. Of
these, 79% (n¼9,009,007) were ischemic
strokes and 21% (n¼2,372,383) were hemor-
rhagic strokes (Table 1). Overall, the largest
age group was the older (66.6%
[n¼7,583,675] of all stroke hospitalizations),
followed by midlife (27.7% [n¼3,148,862])
and young (5.7% [n¼648,853]) adults
(Figure 1). Of all stroke hospitalizations, older
individuals had the highest proportion of
ischemic stroke hospitalizations (81.6%
[n¼6,190,274]), while the highest proportion
of hemorrhagic strokes was noted in young
(35.9% [n¼232,685]) patients. Among
ischemic stroke hospitalizations
(n¼9,009,007), 68.7% (n¼90,274) occurred
in older patients; 26.7% (n¼2,402,565), in
midlife adults; and 4.6% (n¼416,168), in
young adults. However, among hemorrhagic
stroke hospitalizations (n¼2,373,383),
58.7% (n¼1,393,401) occurred in older pa-
tients, 31.5% (n¼746,297) occurred in
midlife adults, and 9.8% (n¼232,685)
occurred in young adults.
Demographic and Comorbidity Profile
The demographic characteristics and comor-
bidity burden of stroke hospitalizations var-
ied significantly across age groups (Table 1).
Midlife hospitalized stroke patients were










































































FIGURE 1. Contribution of young, midlife, and older adults in stroke and cost burden in United States.
STROKE IN THE UNITED STATESwhile older patients were more frequently
women (56% [n¼4,239,664/3,344,011]).
White race was the most frequent in all age
groups, particularly in the older group
(75.6% [n¼4,878,285]), while the largest
proportions of blacks (26.3% [n¼144,786]),
Hispanics (14.4% [n¼79,451]), and others
(8.3% [n¼45,428]) were observed in the
young group.
The prevalence of most chronic condi-
tions, including hypertension, coronary artery
disease, heart failure, vascular disease, and
atrial fibrillation/flutter, was higher in older
adults (P<.001 for all). However, stroke hos-
pitalization in young and midlife adults was
strongly associated with smoking, alcoholism,
and intravenous drug abuse, the latter being
particularly significant in young adults (8.3%
[n¼54,148]) (P<.001 for all). These patterns
were consistent in ischemic and hemorrhagic
stroke (Supplemental Tables 5 and 7,
respectively).Mayo Clin Proc Inn Qual Out n April 2021;5(2):431-441 n https://d
www.mcpiqojournal.orgTemporal Trends in Stroke Hospitalization
During the study period, the overall hospitaliza-
tion rates of stroke per 10,000 hospitalizations
in the United States increased from 31.6 (95%
CI, 31.5 to 31.7) to 33.3 (95% CI, 33.2 to
33.4), with AAPC of 1.5 (95% CI, 1.0, 1.9;
Figure 2A). The hospitalization rates of stroke
increased in young individuals (3.00 [95% CI,
2.9 to 3.1] to 4.3 [95% CI, 4.2 to 4.4]; AAPC,
2.0 [95% CI, 1.6 to 2.4]) and particularly in
midlife adults, which made up the largest
increased rate of the 3 age groups (13.6 [95%
CI, 13.5 to 13.7] to 21.8 [95% CI, 21.7 to
21.9]; AAPC, 3.2 [95% CI, 2.7 to 3.6]).
Conversely, these rates decreased over time in
older persons (138.6 [95% CI, 138.3 to
138.9] to 109.7 [95% CI, 109.4 to 110.0];
AAPC, 1.4 [95% CI, 1.8 to 0.9]).
These trends were consistent in ischemic
and hemorrhagic stroke (Supplemental
Figures 1 and 2, respectively, available online
at https://mcpiqojournal.org).oi.org/10.1016/j.mayocpiqo.2021.01.015 435
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436Temporal Trends in In-Hospital Case
Fatality
The proportion of fatal stroke hospitalizations
was highest in older (11.6% [n¼877,340])
than in young (9.8% [n¼63,328]) and midlife
(9.0% [n¼281,560]) adults hospitalized from
stroke in the United States (P<.001). Overall,
the absolute number of deaths significantly
decreased from 85,980 to 73,910
(AAPC, 1.1; 95% CI, 1.6 to 0.6]).
Although inpatient case fatality decreased in
all age groups (Figure 2B), the decline was
slower in young (AAPC, 2.0; 95%
CI, 2.7 to 1.3]) and midlife
(AAPC, 2.3; 95% CI, 2.8 to 1.7]) adults
compared with older (AAPC, 2.6; 95%
CI, 3.0 to 2.2]) adults. These results
were consistent in ischemic and hemorrhagic
strokes (Supplemental Figures 3 and 4, respec-
tively, available online at https://
mcpiqojournal.org).Trends in LOS and Resource Use
The mean LOS significantly decreased over
time overall (from 7.7 to 6.9 days) in midlife
(from 8.1 to 7.8 days) and older patients
(from 7.4 to 6.2 days), but increased in young
adults (from 9.4 to 9.8 days; P<.001 for trend;
Figure 2C). The highest proportion of patients
discharged home was observed in the midlife
group (55.2% [n¼1,734,978]), to a short-
term care facility in the young group (6.3%
[n¼40,553]), and to a long-term care facility
in the older group (48.2% [n¼3,646,559];
Table 2). Although these trends were consis-
tent in ischemic stroke, the mean LOS
increased in both young (from 10.7 to 11.9
days) and midlife (from 10.3 to 10.8 days) pa-
tients and decreased in older adults in hemor-
rhagic stroke (from 7.9 to 7.2 days; P<.001
for trend; Supplemental Figures 5 and 6,
respectively, available online at https://
mcpiqojournal.org).
Over the entire study period, the cumula-
tive overall inflation-adjusted cost of stroke
was $224.5 billion, which accounted for $14
billion per year. Of this expenditure, 57.0%
($127.9 billion) was represented by older;
33.6% ($75.4 billion), by midlife; and 9.4%
($21.1 billion), by young adults. TheMayo Clin Proc Inn Qual Out n April 2021cumulative total inflation-adjusted cost of
ischemic stroke was $169.6 billion, account-
ing for $10.6 billion per year. Of this amount,
62.2% ($105.5 billion) was contributed by
older; 30.5% ($51.7 billion), by midlife; and
7.3% ($12.3 billion), by young adults. The cu-
mulative total inflation-adjusted hemorrhagic
stroke cost was $66.1 billion, accounting for
$4.1 billion per year, of which 41.6% ($27.4
billion) was contributed by older; 42.8%
($28.3 billion), by midlife; and 15.6% ($10.3
billion), by young adults.
The inflation-adjusted mean cost of stay
increased consistently overall ($16,687 to
$22,224) and in young ($26,266 to
$38,626), midlife ($19,967 to $26,213), and
older ($15,016 to $18,907) patients
(Figure 2D). However, the average annual
growth rate was highest in young adults
(2.44%) compared with midlife (1.72%) and
older (1.45%) patients.
This increase in cost was partly explained
by prolonged LOS and higher use of throm-
bolysis, thrombectomy, craniotomy, echocar-
diogram, ventilators, cardiopulmonary
resuscitation, tracheostomy, septic shock, va-
sopressors, and blood transfusions in young
adults (Supplemental Table 9). These trends
were consistent in ischemic and hemorrhagic
strokes (Supplemental Figures 7 and 8,
respectively, available online at https://
mcpiqojournal.org).DISCUSSION
In this contemporary US national stroke
hospitalization analysis, we observed several
important patterns. First, the demographic
profile, comorbidity burden, and type of
stroke varied across age groups. Second, the
rates of stroke hospitalizations increased
among young and midlife adults but decreased
in older patients, resulting in an overall in-
crease over time. Third, inpatient mortality
decreased, but the decline was slow in young
and midlife adults compared with older
patients. Fourth, the mean LOS increased in
young adults and decreased in midlife and
older patients; and fifth, the mean cost of
stay increased, but the average annual growth
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FIGURE 2. Trends in: (A) stroke rates per 10,000 US hospitalizations in entire cohort, young, midlife, and older adults; (B) inpatient
mortality in entire cohort, young, midlife, and older adults admitted with stroke; (C) length of stay in entire cohort, young, midlife, and
older adults admitted with stroke; and (D) mean adjusted cost of stay in entire cohort, young, midlife, and older adults admitted with
stroke.
STROKE IN THE UNITED STATESwith midlife and older patients. The relatively
higher increase in the cost of care in young
adults was partly explained by longer LOSTABLE 2. Distribution of Economic Variables in Stroke A
Variable Young
Discharge disposition, no. (%) 645,420
Died 63,328 (9.8)
Home 389,983 (60.4)
Short-term care facility 40,553 (6.3)
Long-term care facility 142,152 (21.9)
Against medical advice 11,404 (1.8)
Resource use
Cost ($), median (interquartile
range)
13,694 (7,321-32,5
Length of stay (d), median
(interquartile range)
5 (2-11)
aFor all comparisons, statistical significance was P<.001.
Mayo Clin Proc Inn Qual Out n April 2021;5(2):431-441 n https://d
www.mcpiqojournal.organd increased health care resource use. These
trends were consistent in ischemic and




281,560 (9.0) 877,340 (11.6)
1,734,978 (55.2) 2,753,723 (36.3)
148,538 (4.7) 258,800 (3.4)
939,180 (29.9) 3,646,559 (48.2)
36,874 (1.2) 21,386 (0.3)
23) 10,678 (6,328-22,467) 9,052 (5,605-16,531)
4 (2-9) 4 (3-8)
oi.org/10.1016/j.mayocpiqo.2021.01.015 437
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438Nonwhite individuals, including blacks,
Hispanics, and others, represented a large pro-
portion in the young adult group, whereas 3
of 4 stokes in the older group occurred in
white persons. These findings are consistent
with prior published data.16,17 In the national
Reasons for Geographic and Racial Differences
in Stroke Study (2003-2007), age and sex-
adjusted black/white incidence rate ratios
were higher (4.02) for adults aged 45 to 54
years, while the incidence rate ratio decreased
for those 85 years and older (0.86).17 In the
Greater Cincinnati/Northern Kentucky Stroke
Study, risk ratios for blacks vs whites varied
from 4.18 in 35- to 44-year-old to 1.66 in
65- to 74-year-old patients.16 Similarly, the
Brain Attack Surveillance in Corpus Christi
Project demonstrated that Hispanics had a
higher relative risk for stroke (2.04)
than non-Hispanics whites at a younger age
(45-59 years), but not at an older age (75
years; risk ratio, 1.12).18
These trends toward a higher proportion
of individuals from minority groups among
young stroke cases likely emerge from a multi-
tude of factors, including a higher prevalence
of cardiometabolic risk factors compared
with whites of the same age, such as hyperten-
sion and diabetes and earlier onset of vascular
risk factors in blacks,19-21 lower socioeco-
nomic status,17 lower access to care,16,22 ge-
netic predisposition such as the higher
propensity of cavernous malformations in His-
panics,23 and limited awareness among racial
minorities,18,24 among other factors. For
instance, a county-based study illustrated
that Hispanics had less awareness regarding
risk factors and preventive strategies and
were less likely to perceive stroke symptoms
compared with whites.24
The data reported here confirm a continu-
ation of prior national patterns by illustrating a
higher frequency of hemorrhagic stroke in
younger and midlife adults vs ischemic stroke
in older adults.5 The distribution of particular
risk factors among different age groups might
have influenced the distribution of stroke sub-
types. For instance, the common risk factors
for hemorrhagic stroke are smoking, alcohol
use, drug abuse, and coagulopathy, which
occurred more frequently in the nonelderly
population. Similarly, chronic conditions,
particularly key cardiovascular diseases suchMayo Clin Proc Inn Qual Out n April 2021as atrial fibrillation, explain a higher propor-
tion of ischemic stroke in older adults.
In the Atherosclerosis Risk in Commu-
nities Study, the age-adjusted incidence of
stroke decreased in older (aged 65 years)
patients (absolute decrease of 1.35/1000
person-years) but remained flat in younger
(aged <65 years) patients (absolute decrease
of 0.09/1000 person-years) between 1987
and 2011.6 In the Brain Attack Surveillance
in Corpus Christi Project (2000-2010),
ischemic stroke rates decreased in adults 60
years and older but were static in those aged
45 to 59 years.25 The previous NIS report
up to 2012 showed higher rates of acute
ischemic stroke hospitalizations in those aged
18 to 44 years, stagnant rates for hemorrhagic
stroke, and reduction in hemorrhagic stroke
rates in specific demographic subsets aged 45
to 54 years.5 Our study also demonstrated a
reduction in stroke in older adults; however,
we report 2% and 3% annual increases in
hospitalization rates among young and midlife
adults, respectively. Unhealthy lifestyle
behaviors such as smoking, drug abuse, and
hypertension have likely contributed to these
shifting trends.5 In this regard, the decline in
mortality was slower in younger and midlife
adults than older patients. The notable
improvement in the prognosis of older pa-
tients may reflect progress in medical therapy,
cardiovascular risk mitigation, and use of qual-
ity improvement programs.5,26 However, the
growing stroke burden in young and midlife
patients highlights that cardiovascular preven-
tion and management strategies might not
have penetrated equally in nonelderly patients
and indicate that targeted efforts to these
subgroups are necessary.
Preliminary national data reported that the
total estimated cost of stroke was $45.5 billion
in 2014 to 2015.2 The direct estimated cost
(encompassing outpatient visits, inpatient
stays, emergency department visits, prescribed
medicines, and home health care facilities) was
$28.0 billion.2 The total direct cost of care in
stroke is projected to increase from $36.7 to
$94.3 billion between 2015 and 2035, with
significant growth expected to occur in pa-
tients 80 years and older.27 Between 2002
and 2017, we document the total inflation-
adjusted cost of more than $42.5 billion per
year for stroke hospitalizations, of which;5(2):431-441 n https://doi.org/10.1016/j.mayocpiqo.2021.01.015
www.mcpiqojournal.org
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patients owing to a higher stroke burden
compared with the other age groups. Although
this pattern was consistent for ischemic stroke,
more than 50% of the cost was contributed by
midlife and young adults in hemorrhagic
stroke, which was disproportionally higher
than their combined stroke burden. Similarly,
while the cost of stay increased in older
patients, the average annual growth rate in
the expenditure was relatively higher among
young adults vs midlife (absolute difference,
0.71%) and older (absolute difference,
1.05%) patients, owing to extended LOS and
use of health care resources.
In this context, the growing use of
advanced interventional procedures such as
thrombectomy may affect care costs. In a re-
view of studies conducted in high-income
countries, intravenous thrombolytics imparted
costs ranging from $4000 to $75,000 per
quality-adjusted life-year saved.28 According
to the World Health Organization, an inter-
vention is cost-effective if it costs less than 3
times the annual gross domestic product or
gross national income per capita of a country
per each quality-adjusted life-year saved or
disability-adjusted life-year averted.29 Based
on this standard, thrombolytics for acute
stroke treatment are not a cost-effective invest-
ment, at least for low-income countries.30
Moreover, an increase in indirect cost should
be accounted for given the tradeoff between
improving life expectancy and potentially
increasing morbidity.
Additionally, a higher proportion of
patients being discharged to short-term care
facilities might have further contributed to
the disease's growing economic burden on
young adults. On the same note, the perceived
benefits of stroke and mortality reduction
were counterbalanced by increasing the cost
of a stay, further amplified by a higher propor-
tion of discharge disposition to long-term care
facilities. These concerning statistics should
inform health stakeholders, including policy-
makers, payers, and providers, and call for ur-
gent efforts to ensure value-based care to the
patients.
This analysis has several shortcomings.
Given the NIS database's inherent limitations,
which exclusively focuses on hospitalizations
rather than patients, longitudinal estimates ofMayo Clin Proc Inn Qual Out n April 2021;5(2):431-441 n https://d
www.mcpiqojournal.orgrecurrent hospitalization rates cannot be
computed. Therefore, patients with multiple
strokes over time cannot be identified and
hence can potentially influence the estimates.
We could not adjust for opportunity cost in
this analysis. We could not analyze informa-
tion regarding the anatomy of stroke, severity
of the stroke, disability caused by stroke, and
relevant outcomes. Also, the NIS is an admin-
istrative database and relies on ICD coding for
billing purposes, which is subject to misclassi-
fication.31 The ICD coding system changed
from ICD-9-CM to ICD-1- CM from 2015 to
2016. Moreover, the method of collecting
samples after 2011 changed. That said, we
adjusted for these issues using weights pro-
vided by HCUP. Our analyses did not account
for the outpatient clinical and economic
burden of stroke and were restricted to in-
hospital data. Also, the NIS database does
not contain information on pharmacotherapy
or laboratory values. Despite these limitations,
the NIS data set is a well-validated tool to
analyze a variety of diseases, procedures, and
health care expenditures with reasonable
accuracy.32CONCLUSION
The last 16 years have witnessed significant
temporal changes in stroke hospitalization
rates, inpatient mortality, and associated cost
expenditure, which varied significantly across
different age groups. Young adults demon-
strated an increased burden of stroke and
cost of care and slowed in mortality than
midlife and older patients. Older adults
demonstrated reductions in stroke and mortal-
ity at the expense of a higher cost of care over
time. Further public health interventions
aimed at preventing the onset of stroke across
all age groups, particularly in young and
midlife adults, and interventions to reduce
the cost of care while maximizing value are
needed to curb these trends.SUPPLEMENTAL ONLINE MATERIAL
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